A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well-controlled Type 1 Diabetes.

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well-controlled Type 1 Diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs Gevokizumab (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors XOMA
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record (NCT01788033).
    • 10 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record (NCT01788033).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top